Classification Criteria in Idiopathic Inflammatory Myopathies: Is It Time for an Update?

Area of Science:

• Rheumatology
• Immunology
• Clinical Diagnostics

Background:

• Idiopathic inflammatory myopathies (IIM) classification has evolved significantly since the Bohan-Peter criteria.
• The 2017 European Alliance of Associations for Rheumatology (EULAR)-American College of Rheumatology (ACR) criteria represent a data-driven advancement.
• These criteria have demonstrated good performance across diverse patient populations.

Purpose of the Study:

• To summarize the historical development of IIM classification criteria.
• To outline the rationale for revising the current EULAR-ACR criteria.
• To address the impact of new IIM subtypes and diagnostic advancements.

Main Methods:

• Literature review of historical and current IIM classification systems.
• Analysis of the performance and limitations of the EULAR-ACR criteria.
• Identification of key factors driving the need for criteria revision.

Main Results:

• The historical trajectory of IIM classification shows continuous refinement based on scientific understanding.
• The EULAR-ACR criteria, while valuable, exhibit limitations due to emerging disease knowledge.
• New IIM subtypes and improved diagnostic tools highlight gaps in the existing framework.

Conclusions:

• The progression of IIM classification criteria reflects advancements in understanding these complex autoimmune diseases.
• A revision of the EULAR-ACR criteria is essential to accurately classify emerging IIM subtypes and incorporate new diagnostic insights.
• Updated criteria will enhance research consistency and clinical applicability in diagnosing IIM.